Teduglutide
GLP-2 analog for intestinal rehabilitation and short bowel syndrome. Stimulates intestinal mucosal growth, increases villus height, and improves nutrient absorption in patients with intestinal failure.
Teduglutide is a potent glucagon-like peptide-2 (GLP-2) analog consisting of 33 amino acids. Engineered with DPP-4 resistance, it exhibits enhanced stability and prolonged half-life while maintaining high biological activity. It primarily functions to promote intestinal mucosal repair, enhance nutrient absorption, and improve intestinal barrier function, widely utilized in research and formulation development for short bowel syndrome (SBS), Crohn’s disease (CD), and other intestinal disorders.
| Parameter | Specification |
| CAS | 197922-42-2 |
| Molecular Formula | C₁₆₄H₂₅₂N₄₄O₅₅S |
| Molecular Weight | 3752.13 g/mol |
| Category | GLP-1/Metabolic |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Short bowel syndrome, intestinal failure, parenteral nutrition reduction |
| CAS | 197922-42-2 |
|---|---|
| Applications | Crohn Disease, GLP-2, Intestinal Repair, Short Bowel Syndrome |




